Immediate Impact
85 standout
Citing Papers
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of Gary Noronha being referenced
Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Gary Noronha | 269 | 86 | 66 | 268 | 213 | 13 | 774 | |
| Nowella Durkin | 346 | 36 | 57 | 323 | 247 | 25 | 981 | |
| Gary G. Bennett | 208 | 62 | 44 | 248 | 127 | 24 | 792 | |
| Crescent B. Martin | 128 | 32 | 37 | 334 | 103 | 11 | 786 | |
| Anne Dee | 144 | 34 | 50 | 312 | 118 | 23 | 870 | |
| Neely Williams | 263 | 41 | 53 | 199 | 134 | 22 | 943 | |
| Reuben Berman | 80 | 65 | 24 | 316 | 155 | 15 | 877 | |
| Celia Kamath | 241 | 20 | 67 | 510 | 83 | 33 | 820 | |
| Kenneth J. Tomaszewski | 148 | 35 | 305 | 121 | 145 | 15 | 885 | |
| Karen W. Huskey | 204 | 23 | 12 | 233 | 291 | 13 | 677 | |
| R Sturm | 212 | 29 | 83 | 117 | 105 | 9 | 805 |
All Works
Loading papers...